↓ Skip to main content

Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection

Overview of attention for article published in Frontiers in Microbiology, July 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
5 X users
facebook
1 Facebook page

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
Published in
Frontiers in Microbiology, July 2015
DOI 10.3389/fmicb.2015.00676
Pubmed ID
Authors

Ashwini Benedict, Neha Bansal, Svetlana Senina, Idris Hooper, Lindsay Lundberg, Cynthia de la Fuente, Aarthi Narayanan, Bradford Gutting, Kylene Kehn-Hall

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 3%
Unknown 39 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 18%
Researcher 6 15%
Student > Master 4 10%
Student > Bachelor 3 8%
Professor > Associate Professor 3 8%
Other 3 8%
Unknown 14 35%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 30%
Biochemistry, Genetics and Molecular Biology 7 18%
Immunology and Microbiology 4 10%
Veterinary Science and Veterinary Medicine 1 3%
Computer Science 1 3%
Other 1 3%
Unknown 14 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2015.
All research outputs
#13,207,176
of 22,815,414 outputs
Outputs from Frontiers in Microbiology
#9,848
of 24,772 outputs
Outputs of similar age
#119,680
of 262,367 outputs
Outputs of similar age from Frontiers in Microbiology
#142
of 345 outputs
Altmetric has tracked 22,815,414 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 24,772 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,367 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 345 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.